BRGXOTCServices-Computer Programming, Data Processing, Etc.Fiscal year ends December 31

BIOREGENX, INC.

Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on May 20, 2026

$0.00+0.00 (0.00%)

Close on Oct 16, 2026

Market cap: $3.88M
P/E (TTM): –
Dividend yield: –

BIOREGENX, INC. income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Revenue	1.85	2.34	3.41	0.04	0.20
Cost of Revenue	0.35	0.68	1.10	0	0.00
Gross Profit	1.50	1.66	2.31	0.04	0.20
Research & Development	0.03	0	0.26	–	–
Selling, General & Admin	2.01	5.85	5.23	–	–
Advertising Expenses	0.08	0.07	0.14	0.01	0.01
Operating Expenses	2.75	24	5.72	0.12	0.36
Operating Income	-1.24	-23	-3.41	-0.08	-0.17
Interest Expense	0.30	0.29	0	0	–
Other Non-Operating Income	–	–	-0.46	0	0.07
Asset Impairment Charges	0.73	16	0	–	–
Pretax Income	–	–	-1.28	-0.08	-0.10
Income Tax Expense	–	–	0	0	0
Net Income	-1.54	-23	-3.60	-0.08	-0.10
EPS (Basic)(per share)	0.00	-0.03	-0.01	0.00	0.00
EPS (Diluted)(per share)	0.00	-0.03	-0.01	0.00	0.00
Shares Outstanding (Basic, Weighted)(shares)	960	912	640	270	270
Shares Outstanding (Diluted, Weighted)(shares)	960	912	640	270	270
EBITDA	-1.17	-21	-3.40	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Mar 31, 2026

Profitability, TTM

Gross margin: 81.9%
Operating margin: -62.4%
Net margin: -73.8%
Return on equity, FY2025: 39.0%

Financial strength

Current ratio: 0.05
Debt to equity: -0.04
Debt to assets: 54.2%
Cash to current liabilities: 1.1%

Valuation

P/E ratio: –
Price to sales: 2.20
Price to book: –
Dividend yield: –